FDA greenlights Japan Pharma’s Alzheimer drug



Otsuka Pharmaceutical Co. Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced on Thursday that the United States Food and Drug Administration (FDA) approved supplemental New Drug Application (sNDA)…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento